Overview
Arthur Hooberman is a Hematologist Oncology specialist and a Hematologist in Park Ridge, Illinois. Dr. Hooberman is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Gastrostomy.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Priya Kumthekar is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Kumthekar has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, and Glioma.
Karan Dixit is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Dixit has been practicing medicine for over 14 years and is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Astrocytoma, Glioma, Brain Tumor, Glioblastoma, and Gastrostomy.
Rimas Lukas is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Lukas has been practicing medicine for over 23 years and is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Hooberman isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Laryngeal CancerDr. Hooberman isAdvanced. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Hooberman isAdvanced. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Hooberman isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Hooberman isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Hooberman isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- AngiosarcomaDr. Hooberman isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Hooberman isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Hooberman isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Hooberman isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Hooberman isExperienced. Learn about Breast Cancer.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Hooberman isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).